Fri, Apr 18, 2014, 1:13 PM EDT - U.S. Markets closed for Good Friday

Recent

% | $
Quotes you view appear here for quick access.

Navidea Biopharmaceuticals, Inc Message Board

  • nascrazy nascrazy Jun 15, 2013 10:15 AM Flag

    Why Bother getting into an argument when you know.

    You show little confidence when you have to jump at posters that have 25 cents and immature comments irrelevant to the business.
    Fact is LS is FDA approved and EVERYDAY getting closer to GOLD STANDARD of CARE.
    Replying to those comments show you have some DOUBT and have to DEFEND the Improbable.
    Better let the weak hands go because the ones with those NEGATIVE comments know how valuable this company is going to be and to TAKE your shares NOW is a Lottery Win for them.
    There's NO REASON they hang around spreading FUD for anything other than Financial gain.
    Right now the Shorts want to cover and have started but it is going to get PAINFUL if every move 500K shares drives the price up 50 cents................OUCH!
    There goes the profit and the interest payments too.
    So it is best to stick with the PLAN and let the PROS take you higher then if you're compelled to sell don't go less than $6.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Very true.

      Who among the people who post here as well all throughout the Yahoo! message boards really knows if this stock will go down to $.001 or go up to $50 in the next or five-ten years???

      Each poster is simply reaffirming his call - buy, sell, hold - to be correct by posting all these mumbo-jumbo.

      As it is, the world is already a very difficult place to be in. Why complicate?

      Nobody can predict the future.

      If each of us can, this would be a perfect world.

      Just trade, if you're a day trader or, watch and hope for the best or worst, if you're a long-termer.

      Sentiment: Hold

    • well said!

      Sentiment: Buy

    • no argument here required relative to the baseless and inept fud put forth by pup-pathetic. iwin, equities, mershaw, hendrix, healey, flogo, sharon, callie and others have factually debunked this bashers fud such that his postings are at present seen in reality as illogical, pathological distortions of truth lacking in any/all clarity, and desperation for the purpose of personal enrichment at the expense of honest/diligent NAVB longs/investors. the basher pup-puta on this mb has been neutered and my sincere thanks are exended to the aforementioned longs for doing so; as skillful as any surgeon i might add. fwiw and inmho we patient NAVB longs will be rewarded for persevering through the shorts and their silly bashers. as to when that reward will realised i do not know the date but i do strongly believe it will be SIGNIFICANT and well worth the wait. next basher clown please!

      Sentiment: Buy

      • 2 Replies to palantir777
      • Whaat? Are you demented? Explain why we get rich before 2914 because i do nit seeit nor does wall street it seems

      • you never debunk ANYTHING idiot
        it is a fact that the company is loaded with debt
        it is a fact that many have written than LS makes the shares worth at most 1.5 dollars
        it is a fact that minimal at bets is the advantage of LS over current methods while MORE EXPENSIVE
        it is a fact that Thompson Reuters places NAVB into the most speculative dangerous stock category to own, worse than the other biotech stocks they cover by FAR.
        it is a fact that near-infrared sentinel nodes procedures are as good as LS and they are a valid accepted alternative without using RADIOACTIVITY
        It is a fact that in socialized medicine systems it will not be easy AT ALL to impose LS .
        It is a fact that or I speak to all the wrong doctors or that they truly think that they are NOT convinced and will NOT use LS
        Get a life loser. Debunk this from you head

    • BTW, PUP-PUTA doesn't KNOW as he is incapable of comprehending, hence, his below post. FYI about Pup-Puta!!! Palantir can explain Pup-Puta's mental instability and capability.

      Palantir, care to explain and share some more on Pup-Puta's issues?? Thanks on behalf of everyone on the MB regarding Pup-Puta's mental retardation explanation.

      • 1 Reply to iwinshortslose01
      • Here's the real story vs this green #$%$ Pup-puta is pushing......

        steve brozak interview with life science review
        .

        SB: On March 13, Navidea Biopharmaceuticals Inc. (NAVB:NYSE) got approval for Lymphoseek (technetium Tc 99m tilmanocept), an injectable product to locate metastatic lesions in lymph nodes draining primary tumors. This new diagnostic will be introduced and sold through Cardinal Health Inc. (CAH:NYSE), which is the single largest distributor of isotope diagnostics in the U.S. It already has a price. It already has applied for reimbursement, which is pretty much automatic. The stock went down with the approval announcement. There is a disconnect here. This is a superior product, and Cardinal Health is vending it for indications in breast cancer and melanoma. Navidea also just announced Lymphoseek's ability to identify, with a high degree of specificity, sentinel lymph nodes in patients with head-and-neck cancers. This is an important outcome, with the potential to expand Lymphoseek's use beyond its current indications. It is possible for Lymphoseek to be used in other solid tumors, such as prostate or colorectal cancers. The company is now poised to change oncology staging options.

        TLSR: Steve, metastasis kills. Primary site solid tumors can be resected, but nine out of 10 deaths from solid tumors occur because of metastasis. If this product does what you say, then it's extraordinary.

        SB: Right. And it's true. This product could allow something no one has ever seen before: the ability to stage and treat all solid tumors in the body. It can work for prostate cancer, for lung cancer or for any solid tumor. Clinicians have the ability to figure out if a cancer has progressed beyond the primary site with a gamma detector. What is that worth? We're not talking about hundreds of thousands of patients. We're talking about millions of patients in the U.S. alone.

        Sentiment: Buy

    • Too true. Good post.

    • This is the competition not the poor schmucks here:
      Ann Surg Oncol. 2012 Dec;19(13):4104-11. doi: 10.1245/s10434-012-2466-4. Epub 2012 Jul 3.
      Randomized comparison of near-infrared fluorescence imaging using indocyanine green and 99(m) technetium with or without patent blue for the sentinel lymph node procedure in breast cancer patients.
      van der Vorst JR, Schaafsma BE, Verbeek FP, Hutteman M, Mieog JS, Lowik CW, Liefers GJ, Frangioni JV, van de Velde CJ, Vahrmeijer AL.
      Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.
      BACKGROUND:
      Near-infrared (NIR) fluorescence imaging using indocyanine green (ICG) has the potential to improve sentinel lymph node (SLN) mapping of breast cancer. We performed a randomized clinical trial to assess the value of blue dyes when used in combination with NIR fluorescence. We also preliminarily examined the possibility of performing SLN mapping without radiotracers.
      METHODS:
      Clinical trial subjects were 24 consecutive breast cancer patients scheduled to undergo SLN biopsy. All patients received standard of care using 99(m) technetium-nanocolloid and received 1.6 mL of 500 μM ICG injected periareolarly. Patients were randomly assigned to undergo SLN biopsy with or without patent blue. To assess the need for radiocolloids to localize the SLN or SLNs, the surgeon did not use the handheld gamma probe during the first 15 min after the axillary skin incision.
      RESULTS:
      SLN mapping was successful in 23 of the 24 patients. No significant difference was found in signal-to-background ratio between the groups with and without patent blue (8.3 ± 3.8 vs. 10.3 ± 5.7, respectively, P = 0.32). In both groups, 100 % of SLNs were radioactive and fluorescent, and in the patent blue group, only 84 % of SLNs were stained blue. In 25 % of patients, the use of the gamma probe was necessary to localize the SLN within the first 15 min. This study shows that there is no benefit of using patent blue for SLN mapping in breast c

      • 3 Replies to pup_sydney
      • Hey Palantir..... doesn't the below story make you think of Pup-Puta?

        "When his .38 caliber revolver failed to fire at his intended victim during a hold-up in Long Beach , California would-be robber James Elliot (i.e. Pup-Puta) did something that can only inspire wonder. He peered down the barrel and tried the trigger again. This time it worked."

        This sounds like something Pup-Puta would do based on his MB Posts, don't you think Palantir? LMAO!!!

      • Using green ICG tissue penetration is still limited compared to gamma rays as an example.

        EJNMMI Research 2013, 3:33 doi:10.1186/2191-219X-3-33

        Dual-modality imaging with 99mTc and fluorescent indocyanine green using surface-modified silica nanoparticles for biopsy of the sentinel lymph node: an animal study

        Makoto Tsuchimochi1,2*, Kazuhide Hayama1, Michio Toyama1, Ichiro Sasagawa2 and Norio Tsubokawa3

        "...Near-infrared (NIR) imaging using indocyanine green (ICG) was recently introduced as a new option for imaging sentinel lymph nodes [6-8]. ICG has a long history of use in the clinic for testing liver function and cardiac output and for ophthalmic angiography. Recent studies have demonstrated the usefulness of ICG fluorescence imaging during sentinel lymph node biopsy in comparison to other visual dyes. This efficacy probably stems from the advantages of NIR fluorescence, which allows deeper penetration of photons into living tissue due to its decreased absorption and scattering and minimal tissue autofluorescence at the wavelengths utilized [9]. However, tissue penetration is still limited compared to gamma rays."

      • In both groups, 100 % of SLNs were radioactive and fluorescent, and in the patent blue group, only 84 % of SLNs were stained blue.

        Palantir.......Pup-puta, clearly is not too smart and he keeps proving it over and over and over. This is talking about staining or lighting up the SLNs. LS does much much more as it BINDS to the Node but Pup-puta doesn't understand due to his stupidity it seems. As many of us know, LS is likely to be the first ever SLN Labeling due to it's H&N results. The green is just a substitute for staining the SLN. Totally different and inferior to what LS is doing. Much more is needed than this. Yes, the green appears to be better than VBD for staining but much much more is needed which is why LS will be the SOC for SLN mapping and more. No comparison, but hey, PUP-PUTA can keep trying and maybe some of the naïve readers will sell for him but the real investors, institutions and smart retailers, are smarter than him (much much smarter based on all the stuff he puts out) and this effort will be understood and green will be understood for what it is and it is a lot less than LS.

        He crack's me up as hard as he is trying but is too stupid to realize that most investors see this for what it is. I think he may really believe this is a competitor for LS. It's a competitor for VBD not LS but he really doesn't understand this does he!! Dummy, deceiver, or both is the question about Pup-puta!!

        LOL

    • Well somebody has to protect the dim witted from the deceivers ---and heck-- i dont have anything else to do---

      Sentiment: Strong Buy

 
NAVB
1.660.00(0.00%)Apr 17 4:06 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Weibo Corporation
NasdaqGSThu, Apr 17, 2014 4:00 PM EDT